Form 144 | Neurocrine Biosciences(NBIX.US) Director Proposes to Sell 156.95K in Common Stocks

SEC FILLINGS DISCLOSED/ May 17, $Neurocrine Biosciences(NBIX.US)$ Director SHALINI SHARP intends to sell 1,106 shares of its common stock on May 17, with a total market value of approximately $156.95K

moomoo NewsMay 17 16:34 ET

Form 144 | Neurocrine Biosciences(NBIX.US) Director Proposes to Sell 298.01K in Common Stocks

SEC FILLINGS DISCLOSED/ May 17, $Neurocrine Biosciences(NBIX.US)$ Director RICHARD F POPS intends to sell 2,100 shares of its common stock on May 17, with a total market value of approximately $298.01

moomoo NewsMay 17 16:34 ET

Neurocrine Biosciences(NBIX.US) Director Sells US$1.7 Million in Common Stock

$Neurocrine Biosciences(NBIX.US)$ Director LYONS GARY A sold 12,500 shares of common stock on May 14, 2024 at an average price of $135.6296 for a total value of $1.7 million.Source: Announcement What

moomoo NewsMay 16 17:38 ET

Neurocrine Biosciences(NBIX.US) Officer Sells US$4.14 Million in Common Stock

$Neurocrine Biosciences(NBIX.US)$ Officer ABERNETHY MATT sold 30,000 shares of common stock on May 14, 15, 2024 at an average price of $137.9479 for a total value of $4.14 million.Source: Announcement

moomoo NewsMay 16 17:21 ET

Neurocrine Biosciences Insider Sold Shares Worth $4,138,436, According to a Recent SEC Filing

Matt Abernethy, Chief Financial Officer, on May 14, 2024, sold 30,000 shares in Neurocrine Biosciences (NBIX) for $4,138,436. Following the Form 4 filing with the SEC, Abernethy has control over a tot

MT NewswiresMay 16 16:47 ET

Form 144 | Neurocrine Biosciences(NBIX.US) Officer Proposes to Sell 2.08 Million in Common Stocks

SEC FILLINGS DISCLOSED/ May 15, $Neurocrine Biosciences(NBIX.US)$ Officer MATTHEW C ABERNETHY intends to sell 15,000 shares of its common stock on May 15, with a total market value of approximately $2

moomoo NewsMay 15 22:20 ET